IDEXX LABORATORIES INC /DE Current State and Local Tax Expense (Benefit)
IDEXX LABORATORIES INC /DE (IDXX) reported Current State and Local Tax Expense (Benefit) of $29.25 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-20.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentStateAndLocalTaxExpenseBenefit · last filed 2026-02-20
- IDEXX LABORATORIES INC /DE current state and local tax expense (benefit) for fiscal 2025 was $29.25M, a 21.18% decline from fiscal 2024.
- IDEXX LABORATORIES INC /DE current state and local tax expense (benefit) for fiscal 2024 was $37.11M, a 8.07% decline from fiscal 2023.
- IDEXX LABORATORIES INC /DE current state and local tax expense (benefit) for fiscal 2023 was $40.37M, a 32.23% increase from fiscal 2022.
- IDEXX LABORATORIES INC /DE current state and local tax expense (benefit) for fiscal 2022 was $30.53M, a 59.45% increase from fiscal 2021.
| Period end | Current State and Local Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | $29.25M 10-K · filed 2026-02-20 |
| 2024-12-31 | $37.11M 10-K · filed 2026-02-20 |
| 2023-12-31 | $40.37M 10-K · filed 2026-02-20 |
| 2022-12-31 | $30.53M 10-K · filed 2025-02-21 |
| 2021-12-31 | $19.15M 10-K · filed 2024-02-22 |
| 2020-12-31 | $17.35M 10-K · filed 2023-02-16 |
| 2019-12-31 | $11.97M 10-K · filed 2022-02-16 |
| 2018-12-31 | $10.41M 10-K · filed 2021-02-12 |
| 2017-12-31 | $9.26M 10-K · filed 2020-02-14 |
| 2016-12-31 | $6.61M 10-K · filed 2019-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |